| Name | IXA4 |
|---|---|
| Synonyms |
endoplasmic reticulum (ER) proteostasis,UPR,protein secretion,Inhibitor,Inositol requiring enzyme 1,IXA4,IXA-4,IRE1,unfolded protein response,IXA 4,inhibit
N-(1-(2-(methyl(2-(p-tolyloxy)ethyl)amino)-2-oxoethyl)-1H-pyrazol-4-yl)-3-phenoxypropanamide 1H-Pyrazole-1-acetamide, N-methyl-N-[2-(4-methylphenoxy)ethyl]-4-[(1-oxo-3-phenoxypropyl)amino] IXA4, 10 mM in DMSO N-[1-({methyl[2-(4-methylphenoxy)ethyl]cbamoy l}methyl)-1H-pyrazol-4-yl]-3-phenoxypropanamide |
| Description | IXA4 is a highly selective, non-toxic IRE1/XBP1s activator. IXA4 activates IRE1/XBP1s signaling without globally activating the unfolded protein response (UPR) or other stress-responsive signaling pathways (e.g., the heat shock response or oxidative stress response). IXA4 reduces secretion of APP through IRE1 activation[1]. |
|---|---|
| Related Catalog | |
| In Vitro | IXA4 (10 μM; 4 hours) selectively upregulates XBP1s mRNA, relative to genes regulated by ATF6 (e.g., BiP) or PERK (e.g., CHOP), in other cell lines including Huh7 and SHSY5Y cells[1]. IXA4 (10μM; 18 hours) reduces Aβ levels 50% in conditioned media prepared on CHO7PA2 cells expressing the V717F APP (APPV717F) mutant[1]. IXA4 rescues mitochondrial defects in SH-SY5Y cells expressing disease-relevant APP mutants. IXA4 (10μM; 4 hours) promotes adaptive IRE1/XBP1s signaling, but not RIDD, following 4 hrs of treatment in HEK293T cells[1]. IXA4 also promotes selective transcriptional remodeling of ER proteostasis pathways, relative to cytosolic or mitochondrial pathways[1]. |
| References |
| Molecular Formula | C24H28N4O4 |
|---|---|
| Molecular Weight | 436.5 |
| Exact Mass | 436.21105539 |